Holmen says that utilizing targeted therapies could potentially be the answer, though clinically-tested combinations have historically not done as well as clinicians had hoped.
Sheri Holmen, PhD, associate professor, Department of Surgery, University of Utah School of Medicine, discusses options for treating brain metastases in melanoma. Holmen says that utilizing targeted therapies could potentially be the answer, though clinically-tested combinations have historically not done as well as clinicians had hoped. She adds that combinations are still on the table in terms of treating brain metastases in melanoma, both with other targeted therapies, as well as immunotherapies.
Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond
March 21st 2025Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to support patients’ emotional, physical, and practical needs.
Read More